Cited by 1,676Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in CancerFerroptosis and cancer prognosis

The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.

Hypoxia signalling in cancer and approaches to enforce tumour regression

Pouysségur, Jacques, Dayan, Frédéric, Mazure, Nathalie M.·2006·Nature

Open this paper in CoChat — free account

Abstract

Tumour cells emerge as a result of genetic alteration of signal circuitries promoting cell growth and survival, whereas their expansion relies on nutrient supply. Oxygen limitation is central in controlling neovascularization, glucose metabolism, survival and tumour spread. This pleiotropic action is orchestrated by hypoxia-inducible factor (HIF), which is a master transcriptional factor in nutrient stress signalling. Understanding the role of HIF in intracellular pH (pH(i)) regulation, metabolism, cell invasion, autophagy and cell death is crucial for developing novel anticancer therapies. There are new approaches to enforce necrotic cell death and tumour regression by targeting tumour metabolism and pH(i)-control systems.

Integrity signals

Registry

Crossref · 10.1038/nature04871

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Retracted
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653

Flagged first, then by citations

Show all 104 references

1 of the 104 references couldn’t be matched to a known paper.

Sorted by citations

Items 301–400 of 1,002

Prolyl Hydroxylases 2 and 3 Act in Gliomas as Protective Negative Feedback Regulators of Hypoxia-Inducible Factors
Henze, A., Riedel, J., Diem, T., Wenner, J., Flamme, I., Pouysségur, J., Plate, K. H., & Acker, T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1876 · Cited by 124
Self-citation
Na+-H+ Exchanger, pH Regulation and Cancer
Reshkin, S. J., Cardone, R. A., & Harguindey, S. (2012) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/15748928130108 · Cited by 168
Hypoxic Signaling During Tissue Repair and Regenerative Medicine
Nauta, T. D., van Hinsbergh, V. W. M., & Koolwijk, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151119791 · Cited by 129
SUMOylation of hypoxia-inducible factor-1α reduces its transcriptional activity
Berta, M., Mazure, N. M., Hattab, M., Pouysségur, J., & Brahimi-Horn, M. C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.103 · Cited by 125
Self-citation
CYR61 and αVβ5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
Monnier, Y., Farmer, P., Bieler, G., Imaizumi, N., Sengstag, T., Alghisi, G. C., Stehle, J.-C., Ciarloni, L., Andrejevic-Blant, S., Moeckli, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0841 · Cited by 123
Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma
Nan, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1197 · Cited by 123
The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma
Malekan, M., Ebrahimzadeh, M. A., & Sheida, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111873 · Cited by 123
Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells
Mao, Y., Wang, Y., Dong, L., Zhang, Y., Zhang, Y., Wang, C., Zhang, Q., Yang, S., Cao, L., Zhang, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1384-8 · Cited by 123
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment
Avagliano, A., Fiume, G., Pelagalli, A., Sanità, G., Ruocco, M. R., Montagnani, S., & Arcucci, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00722 · Cited by 128
Role of pH i , and proton transporters in oncogene-driven neoplastic transformation
Reshkin, S. J., Greco, M. R., & Cardone, R. A. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0100 · Cited by 121
Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment
Deep, G., & Panigrahi, G. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v20.i5-6.130 · Cited by 121
Hypoxia-inducible factor (HIF)-3α is subject to extensive alternative splicing in human tissues and cancer cells and is regulated by HIF-1 but not HIF-2
Pasanen, A., Heikkilä, M. M., Rautavuoma, K., Hirsilä, M., Kivirikko, K. I., & Myllyharju, J. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.04.008 · Cited by 125
Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia
Konopleva, M., Thall, P. F., Yi, C. A., Borthakur, G. M., Coveler, A. L., Bueso‐Ramos, C. E., Benito, J., Konoplev, S. N., Gu, Y., Ravandi, F., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.118455 · Cited by 120
Wnt–β-catenin Signaling Protects Against Hepatic Ischemia and Reperfusion Injury in Mice
Lehwald, N., Tao, G., Jang, K. Y., Sorkin, M., Knoefel, W. T., & Sylvester, K. G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.051 · Cited by 123
HIF ‐1α regulates EMT via the Snail and β‐catenin pathways in paraquat poisoning‐induced early pulmonary fibrosis
Zhu, Y., Tan, J., Xie, H., Wang, J., Meng, X., & Wang, R. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12769 · Cited by 123
Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy
Hussain, Z., Rahim, M. A., Jan, N., Shah, H., Rawas‐Qalaji, M., Khan, S., Sohail, M. F., Thu, H. E., Ramli, N. A., Sarfraz, R. M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.018 · Cited by 120
An NIR‐II Photothermally Triggered “Oxygen Bomb” for Hypoxic Tumor Programmed Cascade Therapy
Zhang, S., Li, Z., Wang, Q., Liu, Q., Yuan, W., Feng, W., & Li, F. (2022) · Advanced Materials · doi:10.1002/adma.202201978 · Cited by 119
Architecture of Vanadium‐Based MXene Dysregulating Tumor Redox Homeostasis for Amplified Nanozyme Catalytic/Photothermal Therapy
Zhao, R., Zhu, Y., Feng, L., Liu, B., Hu, Y., Zhu, H., Zhao, Z., Ding, H., Gai, S., & Yang, P. (2023) · Advanced Materials · doi:10.1002/adma.202307115 · Cited by 119
Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway
Dou, C., Zhou, Z., Xu, Q., Liu, Z., Zeng, Y., Wang, Y., Li, Q., Wang, L., Yang, W., Liu, Q., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0505-8 · Cited by 117
Carbonic Anhydrase IX as an Imaging and Therapeutic Target for Tumors and Metastases
Tafreshi, N. K., Lloyd, M. C., Bui, M. M., Gillies, R. J., & Morse, D. L. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-7359-2_12 · Cited by 121
Metastatic Breast Cancer Cells Enter Into Dormant State and Express Cancer Stem Cells Phenotype Under Chronic Hypoxia
de Prati, A. C., Butturini, E., Rigo, A., Oppici, E., Rossin, M., Boriero, D., & Mariotto, S. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25972 · Cited by 121
Association between pH regulation of the tumor microenvironment and immunological state
Hosonuma, M., & Yoshimura, K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1175563 · Cited by 129
Phosphorylation of eIF2α at Serine 51 Is an Important Determinant of Cell Survival and Adaptation to Glucose Deficiency
Muaddi, H., Majumder, M., Peidis, P., Papadakis, A. I., Holčı́k, M., Scheuner, D., Kaufman, R. J., Hatzoglou, M., & Koromilas, A. E. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-01-0023 · Cited by 122
Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer
Nanni, S., Benvenuti, V., Grasselli, A., Priolo, C., Aiello, A., Mattiussi, S., Colussi, C., Lirangi, V., Illi, B., D’Eletto, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35079 · Cited by 115
FM19G11, a New Hypoxia-inducible Factor (HIF) Modulator, Affects Stem Cell Differentiation Status
Moreno‐Manzano, V., Rodríguez-Jiménez, F. J., Aceña, J. L., Fustero, S., Erceg, S., Dopazo, J., Montaner, D. A., Stojković, M., & Sánchez-Puelles, J.-M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008326 · Cited by 121
Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome
Doyen, J., Trastour, C., Ettore, F., Peyrottes, I., Toussant, N., Gal, J., Ilc, K., Roux, D., Parks, S. K., Ferrero, J.-M., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.050 · Cited by 116
Self-citation
Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia‐inducible factors HIF 1α and HIF 2α
Schöning, J., Monteiro, M. J., & Gu, W. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12693 · Cited by 118
Harnessing the hypoxia-inducible factor in cancer and ischemic disease
Brahimi-Horn, M. C., & Pouysségur, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.013 · Cited by 119
Self-citation
DJ-1 as a human oncogene and potential therapeutic target
Cao, J., Lou, S., Ying, M., & Yang, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.11.012 · Cited by 117
Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A
Abdul Rahim, S. A., Dirkse, A., Oudin, A., Schuster, A., Bohler, J., Barthelemy, V., Muller, A., Vallar, L., Janji, B., Golebiewska, A., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.263 · Cited by 111
HIF-1α Mediates Functional Switching of TGF-Β Signaling by Regulating the PKM mRNA Splicing and Metabolic Reprogramming in Non-Small Cell Lung Cancer
Huang, Y., Chen, Z., Lu, T., Bi, G., Li, M., Liang, J., Hu, Z., Zheng, Y., Yin, J., Xi, J., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02188-y · Cited by 117
Regulation of the Warburg Effect in Early-Passage Breast Cancer Cells
Robey, I., Stephen, R. M., Brown, K. S., Baggett, B. K., Gatenby, R. A., & Gillies, R. J. (2008) · Neoplasia · doi:10.1593/neo.07724 · Cited by 114
Proton dynamics in cancer
Huber, V., Milito, A. D., Harguindey, S., Reshkin, S. J., Wahl, M., Rauch, C., Chiesi, A., Pouysségur, J., Gatenby, R. A., Rivoltini, L., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-57 · Cited by 114
Self-citation
A dynamic model of the hypoxia-inducible factor 1-alpha (HIF-1α) network
Nguyen, L. K., Cavadas, M. A. S., Scholz, C. C., Fitzpatrick, S. F., Brüning, U., Cummins, E. P., Tambuwala, M. M., Manresa, M. C., Kholodenko, B. Ν., Taylor, C. T., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.119974 · Cited by 115
Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells
Ouyang, G., Wang, Z., Fang, X., Liu, J., & Yang, C. J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0338-2 · Cited by 115
The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress
Leon, L. M., Gautier‐Isola, M., Allan, R., Ilié, M., Nottet, N., Pons, N., Paquet, A. C., Lebrigand, K., Truchi, M., Fassy, J., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0935-y · Cited by 115
Tumor Dormancy and Interplay with Hypoxic Tumor Microenvironment
Butturini, E., de Prati, A. C., Boriero, D., & Mariotto, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174305 · Cited by 121
Hypoxia in cancer cell metabolism and pH regulation
Brahimi-Horn, M. C., & Pouysségur, J. (2007) · Essays in Biochemistry · doi:10.1042/bse0430165 · Cited by 113
Self-citation
Mitochondrial dysfunctions in cancer: Genetic defects and oncogenic signaling impinging on TCA cycle activity
Desideri, E., Vegliante, R., & Ciriolo, M. R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.023 · Cited by 116
In vivo maps of extracellular pH in murine melanoma by CEST–MRI
Castelli, D. D., Ferrauto, G., Cutrìn, J. C., Terreno, E., & Aime, S. (2013) · Magnetic Resonance in Medicine · doi:10.1002/mrm.24664 · Cited by 113
MicroRNAs in the Imprinted DLK1-DIO3 Region Repress the Epithelial-to-Mesenchymal Transition by Targeting the TWIST1 Protein Signaling Network
Haga, C. L., & Phinney, D. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.387761 · Cited by 120
Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors
Supuran, C. T. (2020) · Journal of Experimental Pharmacology · doi:10.2147/jep.s265620 · Cited by 111
Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1α Expression in an AhR-Independent Fashion
Terzuoli, E., Puppo, M., Rapisarda, A., Uranchimeg, B., Cao, L., Burger, A. M., Ziche, M., & Melillo, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1075 · Cited by 111
Molecular mechanisms of carbonic anhydrase IX‐mediated pH regulation under hypoxia
Pastoreková, S., Ratcliffe, P. J., & Pastorek, J. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07642.x · Cited by 111
DNA Methylation of the SLC16A3 Promoter Regulates Expression of the Human Lactate Transporter MCT4 in Renal Cancer with Consequences for Clinical Outcome
Fisel, P., Kruck, S., Winter, S., Bedke, J., Hennenlotter, J., Nies, A. T., Scharpf, M. O., Fend, F., Stenzl, A., Schwab, M. G., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1180 · Cited by 109
Lactate and Acidity in the Cancer Microenvironment
Parks, S. K., Mueller‐Klieser, W., & Pouysségur, J. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033556 · Cited by 115
Self-citation
Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential
Niklander, S. E. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.642238 · Cited by 122
Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase
Wu, C.-A., Chao, Y., Shiah, S., & Lin, W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.01.025 · Cited by 111
Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism
O′Flaherty, L., Adam, J., Heather, L. C., Zhdanov, A. V., Chung, Y., Miranda, M. X., Croft, J., Olpin, S. E., Clarke, K. J., Pugh, C. W., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq305 · Cited by 110
Metastasis Stimulation by Hypoxia and Acidosis-Induced Extracellular Lipid Uptake Is Mediated by Proteoglycan-Dependent Endocytosis
Menard, J. A., Christianson, H. C., Kucharzewska, P., Bourseau-Guilmain, E., Svensson, K. J., Lindqvist, E., Chandran, V. I., Kjellén, L., Welinder, C., Bengzon, J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2831 · Cited by 110
The Na + /HCO 3 − Co-Transporter SLC4A4 Plays a Role in Growth and Migration of Colon and Breast Cancer Cells
Parks, S. K., & Pouysségur, J. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24930 · Cited by 110
Self-citation
Designing compartmentalized hydrogel microparticles for cell encapsulation and scalable 3D cell culture
Lu, Y., Song, W., An, D., Kim, B. J., Schwartz, R. E., Wu, M., & Ma, M. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01735h · Cited by 113
miR-187-3p inhibits the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by targeting S100A4
Dou, C., Liu, Z., Xu, M. M., Jia, Y., Wang, Y., Li, Q., Yang, W., Zheng, X. M., Tu, K., & Liu, Q. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.011 · Cited by 111
Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
Ashrafizadeh, M., Hushmandi, K., Mirzaei, S., Bokaie, S., Bigham, A., Makvandi, P., Rabiee, N., Thakur, V. K., Kumar, A. P., Sharifi, E., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10325 · Cited by 114
Hypoxia Helps Glioma to Fight Therapy
Murphy, V. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788166637 · Cited by 111
Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours
Ahlskog, J., Schliemann, C., Mårlind, J., Qureshi, U., Ammar, A., Pedley, R. B., & Neri, D. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605200 · Cited by 110
Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway
Ouyang, G., Liu, M., Ruan, K., Song, G., Mao, Y., & Bao, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.030 · Cited by 108
Placental metabolic reprogramming: do changes in the mix of energy-generating substrates modulate fetal growth?
Illsley, N. P., Caniggia, I., & Zamudio, S. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082798ni · Cited by 107
Hypoxia-Induced Energy Stress Inhibits the mTOR Pathway by Activating an AMPK/REDD1 Signaling Axis in Head and Neck Squamous Cell Carcinoma
Schneider, A., Younis, R. H., & Gutkind, J. S. (2008) · Neoplasia · doi:10.1593/neo.08586 · Cited by 107
In vivo pH in metabolic‐defective Ras‐transformed fibroblast tumors: Key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH
Chiche, J., Fur, Y. L., Vilmen, C., Frassineti, F., Daniel, L., Halestrap, A. P., Cozzone, P. J., Pouysségur, J., & Lutz, N. W. (2011) · International Journal of Cancer · doi:10.1002/ijc.26125 · Cited by 114
Self-citation
18F-Fluoromisonidazole PET/CT: A Potential Tool for Predicting Primary Endocrine Therapy Resistance in Breast Cancer
Cheng, J., Li, L., Xu, J., Sun, Y., Zhang, Y., Wang, X., Pan, L., Shao, Z., Zhang, Y., & Liu, G. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.111963 · Cited by 107
Tumor-induced modulation of dendritic cell function
Gottfried, E., Kreutz, M. P., & Mackensen, A. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.10.008 · Cited by 107
MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers
Krutilina, R. I., Sun, W., Sethuraman, A., Brown, M., Seagroves, T. N., Pfeffer, L. M., Ignatova, T. N., & Fan, M. (2014) · Breast Cancer Research · doi:10.1186/bcr3693 · Cited by 106
The tumour microenvironment as an integrated framework to understand cancer biology
Burgos‐Panadero, R., Lucantoni, F., Gamero‐Sandemetrio, E., de la Cruz‐Merino, L., Álvaro, T., & Noguera, R. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.07.010 · Cited by 106
Non‐classical transcriptional regulation of HLA‐G: an update
Moreau, P., Flajollet, S., & Carosella, E. D. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00800.x · Cited by 111
Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy
Lawless, M. W., O'Byrne, K. J., & Gray, S. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00845.x · Cited by 106
Serum lactate dehydrogenase and survival following cancer diagnosis
Wulaningsih, W., Holmberg, L., Garmo, H., Malmström, H., Lambe, M. P., Hammar, N., Walldius, G., Jungner, I., Ng, T., & Hemelrijck, M. V. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.361 · Cited by 106
The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
Myszczyszyn, A., Czarnecka, A. M., Matak, D., Szymański, Ł., Lian, F., Kornakiewicz, A., Bartnik, E., Kukwa, W., Kiéda, C., & Szczylik, C. A. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9611-y · Cited by 109
Targeting lactate transport suppressesin vivobreast tumour growth
Morais-Santos, F., Granja, S., Miranda‐Gonçalves, V., Moreira, A. H. J., Queirós, S., Vilaça, J. L., Schmitt, F. C., Longatto‐Filho, A., Paredes, J., Baltazar, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3910 · Cited by 105
Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia
Hulı́ková, A., Harris, A. L., Vaughan‐Jones, R. D., & Swietach, P. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24221 · Cited by 105
Presence of intratumoral platelets is associated with tumor vessel structure and metastasis
Li, R., Ren, M., Chen, N., Luo, M., Deng, X., Xia, J., Yu, G., Liu, J., He, B., Zhang, X., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-167 · Cited by 108
Integrative Analysis of DNA Methylation and Gene Expression Data Identifies EPAS1 as a Key Regulator of COPD
Yoo, S., Takikawa, S., Geraghty, P. M., Argmann, C., Campbell, J. D., Lin, L., Huang, T., Tu, Z., Feronjy, R., Spira, A. E., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004898 · Cited by 102
Intratumoral fate of functional nanoparticles in response to microenvironment factor: Implications on cancer diagnosis and therapy
Peng, J., Yang, Q., Shi, K., Xiao, Y., Wei, X., & Qian, Z. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.06.007 · Cited by 105
MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1α
Xu, H., Zhao, L., Fang, Q., Sun, J., Zhang, S., Zhan, C., Liu, S., & Zhang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115565 · Cited by 105
HIF-1α promotes the keloid development through the activation of TGF-β/Smad and TLR4/MyD88/NF-κB pathways
Lei, R. L., Li, J., Liu, F., Li, W., Zhang, S., Wang, Y., Chu, X., & Xu, J. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1670508 · Cited by 104
Sirtuins' control of autophagy and mitophagy in cancer
Aventaggiato, M., Vernucci, E., Barreca, F., Russo, M. A., & Tafani, M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107748 · Cited by 103
A Metal‐Phenolic Nanosensitizer Performs Hydrogen Sulfide‐Reprogrammed Oxygen Metabolism for Cancer Radiotherapy Intensification and Immunogenicity
Li, J., Xie, L., Sang, W., Li, W., Wang, G., Yan, J., Zhang, Z., Tian, H., Fan, Q., & Dai, Y. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202200830 · Cited by 103
Expression of hypoxia-inducible factor 1α in thyroid carcinomas
Burrows, N., Resch, J., Cowen, R. L., von Wasielewski, R., Hoang‐Vu, C., West, C., Williams, K. J., & Brabant, G. E. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0251 · Cited by 107
In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity
Li, S., Wu, L., Feng, J., Li, J., Liu, T., Zhang, R., Xu, S., Cheng, K., Zhou, Y., Zhou, S., et al. (2016) · Scientific Reports · doi:10.1038/srep28479 · Cited by 104
Metabolic exchanges within tumor microenvironment
Chiarugi, P., & Cirri, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.027 · Cited by 105
Membrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease
Sahoo, S., Aurich, M. K., Jónsson, J. J., & Thiele, I. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00091 · Cited by 105
Discovery of Small‐Molecule Interleukin‐2 Inhibitors from a DNA‐Encoded Chemical Library
Leimbacher, M., Zhang, Y., Mannocci, L., Stravs, M. A., Geppert, T., Scheuermann, J., Schneider, G., & Neri, D. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201200952 · Cited by 103
Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance
Su, Y., Yang, W., Jiang, N., Shi, J., Chen, L., Zhong, G., Bi, J., Dong, W., Wang, Q., Wang, C., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.26826 · Cited by 103
Yin-Yang Activities and Vicious Cycles in the Tumor Microenvironment
Witz, I. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2917 · Cited by 102
Lack of Hypoxic Response in Uterine Leiomyomas despite Severe Tissue Hypoxia
Mayer, A., Höckel, M., Wree, A., Leo, C., Horn, L., & Vaupel, P. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6339 · Cited by 107
Combination Strategy Targeting the Hypoxia Inducible Factor-1α with Mammalian Target of Rapamycin and Histone Deacetylase Inhibitors
Verheul, H. M. W., Salumbides, B. C., van Erp, K., Hammers, H. J., Qian, D. Z., Sanni, T. B., Atadja, P. W., & Пили, Р. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4306 · Cited by 104
The Peptidyl Prolyl cis/trans Isomerase FKBP38 Determines Hypoxia-Inducible Transcription Factor Prolyl-4-Hydroxylase PHD2 Protein Stability
Barth, S., Nesper, J., Hasgall, P. A., Wirthner, R., Nytko, K. J., Edlich, F., Katschinski, D. M., Stiehl, D. P., Wenger, R. H., & Camenisch, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01324-06 · Cited by 104
Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy
Oliver, L., Olivier, C., Marhuenda, F., Campone, M., & Vallette, F. M. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902030263 · Cited by 104
Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment
Li, M., Li, M., Yin, T., Shi, H., WEN, Y., Zhang, B., Chen, M., Xu, G., Ren, K., & Wei, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4868 · Cited by 106
Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment
Andersen, A. P., Moreira, J. M. A., & Pedersen, S. F. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0098 · Cited by 105
Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis
Deep, G., & Schlaepfer, I. R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071061 · Cited by 101
Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment
Cassim, S., Raymond, V., Assadzadeh, L. D., Lapierre, P., & Bilodeau, M. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1460023 · Cited by 101
Metabolic flexibility in melanoma: A potential therapeutic target
Ruocco, M. R., Avagliano, A., Granato, G., Vigliar, E., Masone, S., Montagnani, S., & Arcucci, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.016 · Cited by 106
ROS and TGFβ: from pancreatic tumour growth to metastasis
Chang, C., & Pauklin, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01960-4 · Cited by 102
Hypoxia and Prostate Cancer Aggressiveness: A Tale With Many Endings
Fraga, A. M., Ribeiro, R. J. T., Príncipe, P., Lopes, C., & Medeiros, R. (2015) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2015.03.006 · Cited by 103
The G protein-coupled receptor T-cell death-associated gene 8 (TDAG8) facilitates tumor development by serving as an extracellular pH sensor
Ihara, Y., Kihara, Y., Hamano, F., Yanagida, K., Morishita, Y., Kunita, A., Yamori, T., Fukayama, M., Aburatani, H., Shimizu, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001165107 · Cited by 100
Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses
Mercier, M. L., Mathieu, V., Haibe‐Kains, B., Bontempi, G., Mijatovic, T., Decaestecker, C., Robert Kiss, A., & Lefranc, F. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318170f892 · Cited by 101
Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses
Rouas‐Freiss, N., Moreau, P., Menier, C., LeMaoult, J., & Carosella, E. D. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.07.003 · Cited by 104
Factors involved in anaerobic growth of Saccharomyces cerevisiae
Snoek, I. S. I., & Steensma, H. Y. (2006) · Yeast · doi:10.1002/yea.1430 · Cited by 102
Vascular mimicry: Triggers, molecular interactions and in vivo models
Wechman, S. L., Emdad, L., Sarkar, D., Das, S. K., & Fisher, P. B. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.06.001 · Cited by 101

Authors: Pouysségur, J., Dayan, F., & Mazure, N. M.
Affiliations: Centre National de la Recherche Scientifique (FR)
Corresponding author: Pouysségur, Jacques
ORCID: Pouysségur, Jacques
Mazure, Nathalie M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2006-05-24
Volume: 441
Issue: 7092
Pages: 437-443
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature04871
OpenAlex: W2082483448
Semantic Scholar: 5bbdcf74ee4cdf263a532b6dbae0b8dd5efb9722
Cited by: 1,676
References: 104
Citations by year: 2026: 19 · 2025: 39 · 2024: 48 · 2023: 75 · 2022: 85 · 2021: 97 · 2020: 87 · 2019: 77 · 2018: 81 · 2017: 68 · 2016: 85 · 2015: 80 · 2014: 103 · 2013: 104 · 2012: 89
FWCI: 6.91
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Ligue Contre le Cancer
Centre National de la Recherche Scientifique
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
Keywords: hypoxia signaling, hypoxia-inducible factor, tumor hypoxia, tumor regression, cancer metabolism, intracellular pH regulation, tumor angiogenesis, glucose metabolism, necrosis, autophagy, cell invasion, cancer therapy, tumor oxygenation
MeSH terms: Animals, Humans, Neoplasms, Neovascularization, Pathologic, Oxygen, Protein Kinases, Signal Transduction, Cell Hypoxia, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia signalling in cancer and approaches to enforce tumour regression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks